SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THE NOVEL CATHEPSIN K INHIBITOR, ONO-5334, IN POSTMENOPAUSAL WOMEN: AN ASCENDING SINGLE AND MULTIPLE DOSE PHASE I STUDY

被引:0
|
作者
Nagase, S. [1 ]
Hashimoto, Y. [2 ]
Ohyama, M. [3 ]
Kuwayama, T. [1 ]
Deacon, S. [1 ]
机构
[1] Ono Pharma UK Ltd, London, England
[2] Ono Pharmaceut Co Ltd, Tsukuba, Ibaraki, Japan
[3] Ono Pharmaceut Co Ltd, Osaka, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:339 / 339
页数:1
相关论文
共 50 条
  • [21] A Phase I, Single-Ascending-Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DS-2969b, a Novel GyrB Inhibitor
    Dennie, Justin
    Vandell, Alexander G.
    Inoue, Satoshi
    Gajee, Roohi
    Pav, Joseph
    Zhang, George
    Zamora, Cynthia
    Masuda, Nobuhisa
    Uchiyama, Minoru
    Yamada, Makiko
    Senaldi, Giorgio
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (12): : 1557 - 1565
  • [22] A phase 1 single ascending dose study of the safety, tolerability and pharmacokinetics of CRV431
    Armas, Danielle
    Snyder, Michael
    Trepanier, Daniel
    Ure, Daren
    Greytok, Jill
    Foster, Robert
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E464 - E465
  • [23] PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY, AND TOLERABILITY OF BI 11634, A NOVEL DIRECT ORAL FACTOR XA INHIBITOR, IN A SINGLE ASCENDING DOSE STUDY
    Huang, Fenglei
    Formella, Stephan
    Schepers, Cornelia
    Rubano, Vanessa
    MacGregor, Thomas R.
    Breithaupt-Groegler, Kerstin
    Smith, John
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1061 - 1061
  • [24] Safety and pharmacodynamics of ascending oral doses of the cathepsin K inhibitor, balicatib, in postmenopausal women.
    Collins, W. C. J.
    Roy, S. K.
    Pillai, G.
    Woodworth, T. G.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S115 - S115
  • [25] A Randomized, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Novel Insulin Dimer
    Walford, Geoffrey A.
    Duncan, Kelly E.
    Hernandez, Moises
    Vaddady, Pavan
    Hompesch, Marcus
    Morrow, Linda
    Stoch, S. Aubrey
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (01) : 125 - 132
  • [26] Pharmacokinetics, pharmacodynamics, and safety of izuforant, an H4R inhibitor, in healthy subjects: A phase I single and multiple ascending dose study
    Jin, Byung Hak
    Hong, Taegon
    Yoo, Byung Won
    Kim, Choon Ok
    Kim, Dasohm
    Kim, Youn Nam
    Park, Min Soo
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (10):
  • [27] SAFETY, TOLERABILITY AND PHARMACOKINETICS OF RG1678, A NOVEL GLYCINE REUPTAKE INHIBITOR: A MULTIPLE ASCENDING DOSE STUDY IN HEALTHY VOLUNTEERS.
    Boetsch, C.
    Hofmann, C.
    Martin-Facklam, M.
    Banken, L.
    Biedinger, U.
    Patat, A.
    Boutouyrie, B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S57 - S57
  • [28] SAFETY, TOLERABILITY AND PHARMACOKINETICS OF RG1678. A NOVEL GLYCINE REUPTAKE INHIBITOR: A SINGLE ASCENDING DOSE STUDY IN HEALTHY VOLUNTEERS.
    Martin-Facklam, M.
    Hofmann, C.
    Banken, L.
    Alberati, D.
    Schmitt, G.
    Parrott, N.
    Hainzl, D.
    Robson, R.
    Nave, S.
    Boutouyrie, B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S57 - S57
  • [29] Phase I Single Ascending Dose and Food Effect Study in Healthy Adults and Phase I/IIa Multiple Ascending Dose Study in Patients with Pulmonary Tuberculosis to Assess Pharmacokinetics, Bactericidal Activity, Tolerability, and Safety of OPC-167832
    Dawson, Rodney
    Diacon, Andreas H.
    Narunsky, Kim
    De Jager, Veronique R.
    Stinson, Kelly W.
    Zhang, Xiaoyan
    Liu, Yongge
    Hafkin, Jeffrey
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (06)
  • [30] Safety, Tolerability, and Pharmacokinetics of the Mineralocorticoid Receptor Modulator AZD9977 in Healthy Men: A Phase I Multiple Ascending Dose Study
    Whittaker, Andrew
    Kragh, Asa M.
    Hartleib-Geschwindner, Judith
    Albayaty, Muna
    Backlund, Anna
    Greasley, Peter J.
    Heijer, Maria
    Kjaer, Magnus
    Forte, Pablo
    Unwin, Robert
    Wernevik, Linda
    Ericsson, Hans
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (02): : 275 - 283